No abstract

BACKGROUND Clinical features, diagnosis, medicine treatment, epidemiological characteristics, and the therapy of 26 confirmed cases were analyzed. OBJECTIVE To provide a scientific basis for formulating epidemic prevention with control strategies and measures. METHODS According to the Program of Investigation on Cases of Pneumonia Caused by Novel Coronavirus Infection in the fifth edition National Health Commission release guideline about Prevention, Treatment, and Control of Infection. An epidemiological survey, clinical features, treatment guidelines was conducted for the 26 patients who were diagnosed with COVID-19 and have been treated in The General Hospital since Jan 2020. RESULTS The ratio of males and females were 3.25∶1. 25 cases of Han nationality of Chinese. 22 cases (84.62%) were more than 18 years old. There were 15 cases from the local area (57.69%), and 6 cases were from Hubei province (23.08%). There were 20(76.92%) cases of fever, 14(53.85%) cases of weakness, and 8(30.77%) cases of dry cough. Progressive muscle relaxation (PMR) therapy could help covid-19 patients overcome anxiety and sleep problems, which may give a boost in their mental strength to fight against this covid-19 during the staying isolation ward. Both the clinical results and quality of evidence will reveal for Ribavirin, Lopinavir/Ritonavir, Moxifloxacin and Arbidol Hydrochloride combination with supportive drugs are probably major effective treatments in this study challenges that face frontline physicians who treat patients in a medical setting and evaluate prophylaxis for novel high-risk environments formed by large quarantined and isolated populations. CONCLUSIONS Most cases are male. The people aged more than 40 years old are the population group at high risk of the disease. Most of the early cases had a history of travel or business trips to Wuhan, and nearly 50% of cases were caused by living together and close contact. Different Combination drugs use for covid-19 are clinically successfully effective in published literature, including this study.

Spinal tuberculosis (TB), caused by mycobacterium tuberculosis, is one of the oldest diseases in the world. Spinal TB represents 50% of bone and joint TB. If spinal TB is not diagnosed and treated in time, it could cause spinal cord infection, nerve compression and paralysis.  Spinal TB often causes abscesses formation, spinal dysfunction, spinal instability, and kyphosis onset disorder. Most spinal TB can be cured by non-surgical treatment. Surgery is the ultimate method of treatment of spinal tuberculosis and it is used for eliminating lesions, relieving spinal cord and nerve compression, correcting kyphosis and building spine stability. At present, spinal TB surgical approaches are mainly posterior approach, combined anterior-posterior approach and minimally invasive techniques. The present review summarizes the advantages, disadvantages and indications for each surgical method.

Background: Chondrosarcomas are a rare tumor that has a variable biological characteristic, also their treatment clinically and surgically is controversial. So, authors are analyzing the related risk factors of influencing the postoperative recurrence of chondrosarcoma. Methods: Retrospective analysis of clinical data, a total of 65 cases of chondrosarcoma were collected from January 2002 to June 2016 in our hospital database and divided into 2 groups (pelvic and non-pelvic chondrosarcoma) with 3 ethnic class (Han, Uyghur, and other nationalities) of Chinese people. The clinical characteristics and prognostic risk factors of chondrosarcoma recurrence were analyzed by different statistic methods. Results: The age, sex, nationality, surgical method, pathological grade and Enneking stage of chondrosarcoma patients were not significantly correlated with postoperative recurrence (P>.05); but the site of tumor growth was significantly correlated with postoperative recurrence (P<0.001). Cox regression model multivariate analysis showed that tumor growth site was an independent factor influencing postoperative recurrence of chondrosarcoma, and the risk of postoperative recurrence of pelvic chondrosarcoma was 3.610 times higher than non-pelvic chondrosarcoma. Conclusion: The recurrence rate of pelvic chondrosarcoma was significantly higher than non-pelvic chondrosarcoma.

No abstract